Page last updated: 2024-09-04

jte 522 and mobic

jte 522 has been researched along with mobic in 1 studies

Compound Research Comparison

Studies
(jte 522)
Trials
(jte 522)
Recent Studies (post-2010)
(jte 522)
Studies
(mobic)
Trials
(mobic)
Recent Studies (post-2010) (mobic)
61171,739396936

Protein Interaction Comparison

ProteinTaxonomyjte 522 (IC50)mobic (IC50)
Prostaglandin G/H synthase 1Homo sapiens (human)1.5593
Prostaglandin G/H synthase 2Homo sapiens (human)0.4364
Prostaglandin G/H synthase 2Mus musculus (house mouse)0.1514

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brideau, C; Chan, CC; Charleson, S; Cromlish, W; Ethier, D; Evans, JF; Ford-Hutchinson, AW; Gauthier, JY; Gordon, R; Gresser, M; Guay, J; Kargman, S; Kennedy, B; Leblanc, Y; Léger, S; Mancini, J; O'Neill, GP; Ouellet, M; Percival, MD; Perrier, H; Prasit, P; Riendeau, D; Rodger, I; Wang, Z; Zamboni, R1

Other Studies

1 other study(ies) available for jte 522 and mobic

ArticleYear
The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor.
    Bioorganic & medicinal chemistry letters, 1999, Jul-05, Volume: 9, Issue:13

    Topics: Administration, Oral; Animals; Biological Availability; CHO Cells; Cricetinae; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Humans; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Lactones; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Sulfones

1999